A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination

NCT01963338 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Pain
Vaccination Adverse Event

Interventions

DEVICE: Intradermal injection in the forearm (0,1cc NaCl 0,9%)
DEVICE: Intradermal injection in the upper arm (0,1cc NaCl 0,9%)
DRUG: Intramuscular injection in the upper arm (0,5cc NaCl 0,9%)

Sponsor

Pierre Van Damme